Vivani Medical (NASDAQ:VANI) Announces Quarterly Earnings Results

Key Points

• Vivani Medical reported a quarterly earnings per share (EPS) of ($0.12), missing the consensus estimate of ($0.09) by ($0.03).
• The company's stock price is currently at $1.26, with a market capitalization of $74.64 million and a one-year trading range between $0.91 and $1.80.
• HC Wainwright has reissued a "buy" rating on Vivani Medical, setting a price target of $4.00 per share.

Vivani Medical (NASDAQ:VANI - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.02), Zacks reports.

Vivani Medical Price Performance

NASDAQ:VANI remained flat at $1.25 during mid-day trading on Monday. 16,764 shares of the company were exchanged, compared to its average volume of 107,856. Vivani Medical has a 52 week low of $0.91 and a 52 week high of $1.80. The business's 50-day simple moving average is $1.34 and its two-hundred day simple moving average is $1.18. The stock has a market capitalization of $74.05 million, a price-to-earnings ratio of -2.78 and a beta of 2.99.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a "buy" rating and issued a $4.00 price objective on shares of Vivani Medical in a research note on Monday, May 19th.

About Vivani Medical

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.